While they induced cell death in a p53-dependent manner in cells harboring wild-type p53, they also exhibited p53-independent/MDM2-dependent activity in p53-null cells, suggesting that these compounds can be used beyond wild-type p53-expressing cancers 93. Here, MDM2 is linked to cancer.